Amphora Discovery this week announced the appointment of William Janzen, a company co-founder, as president and chief operating officer.
Prior to his promotion, Janzen served as Amphora’s vice president of operations and chief technology officer. Prior to co-founding Amphora, Janzen spent 18 years in pharmaceutical R&D at Eli Lilly and Sphinx Pharmaceuticals.
Galapagos this week said it has added Rudi Pauwels as an independent, non-executive board member.
Pauwels is a co-founder of Galapagos, as well as Tibotec (now a part of Johnson & Johnson) and Virco.
Galapagos also said that Wilson Totten and David Stone stepped down as board members in December. Totten had served as a non-executive board member since Oct. 2004, while Stone had served since Galapagos’ Oct. 2005 acquisition of BioFocus.